Showing results (71-80 of 239) with videos related to

Sort By:
Pageof 24
Cancer Treatment Reviews|July 31, 2012
A review of the treatment of endocrine responsive metastatic breast cancer in postmenopausal womenFatima Cardoso, Joachim Bischoff, Etienne Brain, et al.
BMC Genomics|August 23, 2008
Comparison of prognostic gene expression signatures for breast cancerBenjamin Haibe-Kains, Christine Desmedt, Fanny Piette, et al.
ESMO Open|October 13, 2017
Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patientsAnastassia Negrouk, Denis Lacombe, Fatima Cardoso, et al.
ESMO Open|September 7, 2020
Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapiesShani Paluch-Shimon, Nathan I Cherny, Elisabeth G E de Vries, et al.
Seminars in Oncology Nursing|October 13, 2023
Patient-Reported Outcome Measures to Improve the Care Continuum for Patients With Metastatic Breast Cancer: Opportunities and Implications for Nursing PracticeKelly M de Ligt, Belle H de Rooij, Linetta B Koppert, et al.
JCO Oncology Practice|April 7, 2023
ASCO Policy Statement on Biosimilar and Interchangeable Products in OncologyGladys Rodriguez, Joan Mancuso, Gary H Lyman, et al.
Breast Cancer Research and Treatment|June 26, 2013
A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancerR Charles Coombes, Fatima Cardoso, Nicolas Isambert, et al.
JMIR Formative Research|December 29, 2022
Effectiveness of Secondary Risk-Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation StudyJelena Maksimenko, Pedro Pereira Rodrigues, Miki Nakazawa-Miklaševiča, et al.
JMIR Formative Research|March 17, 2023
Correction: Effectiveness of Secondary Risk-Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation StudyJelena Maksimenko, Pedro Pereira Rodrigues, Miki Nakazawa-Miklaševiča, et al.
Breast (Edinburgh, Scotland)|November 26, 2025
Reducing stigma, isolation, and misconceptions in advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 8)Ranjit Kaur, Rania A Azmi, Sarah Kutika Nyagabona, et al.
Pageof 24